Should I buy or sell BioPharma Credit stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioPharma Credit in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BOPCF shares. View BOPCF analyst ratings or view top-rated stocks .

How have BOPCF shares performed in 2024?

BioPharma Credit's stock was trading at $0.84 at the beginning of 2024. Since then, BOPCF stock has increased by 6.0% and is now trading at $0.89. View the best growth stocks for 2024 here .

Are investors shorting BioPharma Credit?

BioPharma Credit saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 200 shares, an increase of 100.0% from the March 31st total of 100 shares. Based on an average trading volume of 16,400 shares, the days-to-cover ratio is currently 0.0 days. View BioPharma Credit's Short Interest .

How do I buy shares of BioPharma Credit?

Shares of BOPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BOPCF

BioPharma Credit (BOPCF) Stock Price, News & Analysis

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)

Free BOPCF Stock Alerts

$0.89

0.00 (0.00%)

(As of 05/17/2024 ET)

Today's Range: $0.89
▼
$0.89
50-Day Range: $0.89
▼
$0.92
52-Week Range: $0.54
▼
$1.25

Volume: N/A
Average Volume: 559,525 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Ad Stansberry Research

Everybody laughed when he recommended Netflix

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.

About BioPharma Credit Stock (OTCMKTS:BOPCF)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

BOPCF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BOPCF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: OTCMKTS:BOPCF
CUSIP: N/A
CIK: N/A
Web: www.bpcruk.com
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Pedro Gonzalez de Cosio
Investment Manager
Mr. Pablo Gerardo Legorreta (Age 59)
Investment Manager
Mr. Martin G. Friedman (Age 59)
Investment Manager

BOPCF Stock Analysis - Frequently Asked Questions

Should I buy or sell BioPharma Credit stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioPharma Credit in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BOPCF shares.
View BOPCF analyst ratings or view top-rated stocks.
How have BOPCF shares performed in 2024?: BioPharma Credit's stock was trading at $0.84 at the beginning of 2024. Since then, BOPCF stock has increased by 6.0% and is now trading at $0.89.
View the best growth stocks for 2024 here.
Are investors shorting BioPharma Credit?: BioPharma Credit saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 200 shares, an increase of 100.0% from the March 31st total of 100 shares. Based on an average trading volume of 16,400 shares, the days-to-cover ratio is currently 0.0 days.
View BioPharma Credit's Short Interest.
How do I buy shares of BioPharma Credit?: Shares of BOPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BOPCF) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

BioPharma Credit (BOPCF) Stock Price, News & Analysis

About BioPharma Credit Stock (OTCMKTS:BOPCF)

BOPCF Stock Price History

BOPCF Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

BOPCF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info